Structural Insights into the Molecular Design of HER2 Inhibitors
暂无分享,去创建一个
Avinash C. Tripathi | Pankaj Kumar Sonar | Ravindranath Rathore | Shailendra K. Saraf | P. Sonar | A. Tripathi | S. Saraf | R. Rathore
[1] Shu Liu,et al. Application of Consensus Scoring and Principal Component Analysis for Virtual Screening against β-Secretase (BACE-1) , 2012, PloS one.
[2] Jiwon Choi,et al. Optimization of High Throughput Virtual Screening by Combining Shape-Matching and Docking Methods , 2008, J. Chem. Inf. Model..
[3] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[4] P. Traxler,et al. Tyrosine kinases as targets in cancer therapy – successes and failures , 2003, Expert opinion on therapeutic targets.
[5] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[6] Tomohiro Ohashi,et al. Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors. , 2013, Bioorganic & medicinal chemistry.
[7] J. Pin,et al. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.
[8] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[9] T. Taniguchi,et al. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. , 2011, Journal of medicinal chemistry.
[10] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[11] et al.,et al. In-silico predictive mutagenicity model generation using supervised learning approaches , 2012, Journal of Cheminformatics.
[12] Wei Zhao,et al. A statistical framework to evaluate virtual screening , 2009, BMC Bioinformatics.
[13] M. Sliwkowski,et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. , 2003, Molecular cell.
[14] Hanna Geppert,et al. Integrating Structure‐ and Ligand‐Based Virtual Screening: Comparison of Individual, Parallel, and Fused Molecular Docking and Similarity Search Calculations on Multiple Targets , 2008, ChemMedChem.
[15] B. Park,et al. Androgen receptor as a targeted therapy for breast cancer. , 2012, American journal of cancer research.
[16] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[17] Woody Sherman,et al. Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis , 2009, J. Chem. Inf. Model..
[18] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[19] R. O'Regan,et al. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy , 2012, Chemotherapy research and practice.
[20] M. Murcko,et al. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.
[21] Monilola A. Olayioye,et al. The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.
[22] Hsuan-Liang Liu,et al. The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies , 2011, Journal of Biomedical Science.
[23] Amanda C. Schierz. Virtual screening of bioassay data , 2009, J. Cheminformatics.
[24] Robert P. Sheridan,et al. Protocols for Bridging the Peptide to Nonpeptide Gap in Topological Similarity Searches , 2001, J. Chem. Inf. Comput. Sci..